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ABSTRACT
Acetyl-CoA Carboxylase catalyzes the first commit-
ted step in fatty acid synthesis. Escherichia coli
acetyl-CoA carboxylase is composed of biotin
carboxylase, carboxyltransferase and biotin
carboxyl carrier protein functions. The accA and
accD genes that code for the a- and b-subunits,
respectively, are not in an operon, yet yield an a2b2
carboxyltransferase. Here, we report that
carboxyltransferase regulates its own translation
by binding the mRNA encoding its subunits. This
interaction is mediated by a zinc finger on the
b-subunit; mutation of the four cysteines to alanine
diminished nucleic acid binding and catalytic
activity. Carboxyltransferase binds the coding
regions of both subunit mRNAs and inhibits transla-
tion, an inhibition that is relieved by the substrate
acetyl-CoA. mRNA binding reciprocally inhibits
catalytic activity. Preferential binding of carboxyl-
transferase to RNA in situ was shown using
fluorescence resonance energy transfer. We
propose an unusual regulatory mechanism by
which carboxyltransferase acts as a ‘dimmer
switch’ to regulate protein production and catalytic
activity, while sensing the metabolic state of the cell
through acetyl-CoA concentration.
INTRODUCTION
Acetyl-CoA carboxylase (ACCase, EC 6.4.1.2) catalyzes
the ﬁrst committed step in fatty acid biosynthesis in all
organisms. The overall reaction is the biotin-dependent
carboxylation of acetyl-CoA to form malonyl-CoA and
it takes place in two separate half-reactions.
The ﬁrst half-reaction is catalyzed by biotin
carboxylase, where ATP is used to activate bicarbonate
for carboxylation of biotin. The natural substrate is the
biotin carboxyl carrier protein (designated as
Enzyme-biotin in the above scheme). The second
half-reaction, catalyzed by carboxyltransferase, transfers
the activated carboxyl group from carboxybiotin to
acetyl-CoA to form malonyl-CoA. In eukaryotes, each
of the three diﬀerent proteins, biotin carboxylase, biotin
carboxyl carrier protein and carboxyltransferase form
individual domains in a single polypeptide chain. In
contrast, Escherichia coli encodes separate polypeptides
generating a homodimeric biotin carboxylase (BC),
biotin carboxyl carrier protein (BCCP) and an a2b2
heterotetrameric carboxyltransferase (CT) (1).
Because the reaction involves two separate
half-reactions, coordinated expression of the genes
coding for the various subunits of bacterial ACCase is
essential in order to achieve eﬃcient conversion of
substrate to product. This is readily accomplished for
the ﬁrst half-reaction because the genes coding for biotin
carboxylase (accC) and the biotin carboxyl carrier protein
(accB) are in a single operon that is transcriptionally con-
trolled (2,3). However, the genes encoding the CT a (accA)
and CT b (accD) subunits are not in an operon, but are
found on nearly opposite poles of the chromosome (4.50
and 52.40, respectively) in opposing directions (4,5). Yet,
the expression of accA and accD should yield
stoichiometric amounts of the a- and b-subunits to form
the a2b2 heterotetramer of CT. Sequence analyses reveal
no obvious clues to a mechanism of concerted expression
of accA and accD, however, an alternative to
transcriptional control for modulating expression of
accA and accD has been suggested (2).
The crystal structures of both E. coli (PDB: 2f9y) and
Staphylococcus aureus (PDB: 2f9i) CT reveal a Cys4-type
zinc ribbon motif on the b-subunit (6) (Figure 1). The zinc
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electropositive surface potential, whereas the rest of the
protein has a net electronegative surface potential (6).
Zinc-ﬁnger domains are commonly associated with
nucleic acid-binding proteins and previous studies have
shown that CT does bind DNA, albeit non-speciﬁcally
(7). Notably, DNA binding inhibited catalysis while the
substrates inhibited DNA binding (7). In other words,
DNA binding and catalysis are reciprocally related,
implying a physiological role for nucleic acid binding.
In this report, we show that an unusual regulatory
mechanism exists by which CT autoregulates activity
in response to metabolic needs. Speciﬁcally, we show
that the zinc domain of CT is not only required for
catalysis, but that it also mediates binding to the mRNA
coding for the a- and b-subunits of carboxyltransferase
so that CT can act as a ‘dimmer switch’ to regulate
translation. These properties of the zinc domain, which
is unique to bacterial CT, provide a mechanism for
regulating enzymatic activity and for coordinating expres-
sion of the genes coding for the a- and b-subunits of
carboxyltransferase.
MATERIALS AND METHODS
Reagents
Restriction enzymes and T4 DNA ligase were from New
England Biolabs. Pfu Turbo DNA polymerase was from
Stratagene. The cloning and expression vector pETBlue-2
and the E. coli host strains NovaBlue and BL21(DE3)
were from Novagen. Primers were synthesized by MWG
Biotech. In vitro transcription kit was from Ambion. T7
in vitro transcription/translation kit was from Qiagen.
[a-
32P]UTP (3000Ci/mmol) and [
35S]L-Methionine
(>1000Ci/mmol) were from PerkinElmer. His-binding
cartridges and all other reagents were from Sigma.
Construction of expression vectors
The genes accA and accD coding for the a- and b-subunits
of carboxyltransferase were overexpressed linked in a
minioperon similar to the one described by Blanchard
and Waldrop (8) except that the expression vector
pETBlue-2 was used and the his-tag was placed on the
C-terminus of the b-subunit. To construct the minioperon,
the gene encoding the a-subunit of E. coli CT was
ampliﬁed by PCR using pCZB2 (8) as template and
primers CTa5 and CTa3 (Table 1), digested with NcoI
and HindIII, and cloned into equivalently digested
pETBlue-2 to generate the plasmid pGDM8. To make
possible the use of the NcoI restriction site, an amino
acid mutation, S2A, was introduced near the N-terminus
of accA. This mutation had no eﬀect on the functions of
the enzyme, either nucleic acid binding or catalytic
activity. The CTa3 primer allowed incorporation of the
modiﬁed ribosomal binding site after the accA stop
codon. The gene for the wild-type b-subunit of E. coli
CT was ampliﬁed by PCR using pCZB1 (8) as template
and primers CTb5 and CTb3, digested with HindIII and
XhoI, and cloned into equivalently digested pGDM8 to
generate the plasmid pGDM9, which was used for
coexpression of both genes.
Site-directed mutagenesis
The cysteines in the zinc domain of the CT b-subunit were
mutated to alanine using the method of overlap extension
(9). Four single variants were generated, resulting in
plasmids pGDM12-15. Complementary oligonucleotides
containing speciﬁc alterations in the nucleotide sequence
(e.g. C30A5 and C30A3) were used to generate two DNA
fragments having overlapping ends. These fragments were
combined and used as the template in a subsequent PCR
reaction using primers CTb5 and CTb3 (Table 1) to
generate the full-length accD gene with the desired
mutation (e.g. C30A). Three multiple cysteine to alanine
variants were generated by sequential site-directed
mutagenesis of the C27A accD gene using the pairs of
Figure 1. The Cys4-type Zn ribbon of E. coli carboxyltransferase with
the Zn atom shown in gray coordinated by four cysteine residues
(PDBID: 2f9y).
Table 1. List of primers used for mutagenesis
Oligonucleotide 
CTa5 
CTa3 
CTb5 
CTb3 
C27A5 
C27A3 
C30A5 
C30A3 
C46A5 
C46A3 
C49A5 
C49A3 
C27/30A5 
C27/30A3 
C46/49A5 
C46/49A3 
eYFP5 
eYFP3 
CCCCATGGCTCTGAATTTCCTTGAT 
GGCAAGCTTCTCCTTACGCGTAACCGTAGCTCAT 
GGCAAGCTTATAATGAGCTGGATTGAACGAATT 
GGCCTCGAGGGCCTCAGGTTCCTGATCCGG 
GGGTGTGGACTAAGGCTGATAGCTGCGGTC 
GACCGCAGCTATCAGCCTTAGTCCACACCC 
CTAAGTGTGATAGCGCCGGTCAGGTTTTAT 
ATAAAACCTGACCGGCGCTATCACACTTAG 
GTAATCTTGAGGTCGCTCCGAAGTGTGACC 
GGTCACACTTCGGAGCGACCTCAAGATTAC 
AGGTCTGTCCGAAGGCTGACCATCACATGC 
GCATGTGATGGTCAGCCTTCGGACAGACCT 
CTAAGGCTGATAGCGCCGGTCAGGTTTTAT 
ATAAAACCTGACCGGCGCTATCAGCCTTAG 
AGGTCGCTCCGAAGGCTGACCATCACATGC 
GCATGTGATGGTCAGCCTTCGGAGCGACCT 
GGCCTCGAGATGGTGAGCAAGGGCGAGGAGCTG 
GGCTTAATTAATTACTTGTACAGCTCGTCCATGCCGAG 
Sequence (5'–3')
The boxed nucleotides are the mutations from wild-type.
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and C27/30A5 and C27/30A3. All constructs were
sequenced to conﬁrm the mutations and verify there
were no other changes.
Expression, puriﬁcation and enzymatic assay
The plasmids encoding wild-type and CT variants were
transformed into E. coli BL21(DE3) and grown as
described by Blanchard and Waldrop (8) with the follow-
ing exceptions. The temperature was reduced to 25 C
prior to induction with 2.8mM b-lactose. Expressed
protein was puriﬁed by nickel aﬃnity chromatography
using a HisSelect cartridge (Sigma) following the manu-
facturer’s protocol. The wash buﬀer contained 10mM
imidazole, 300mM NaCl, 50mM KH2PO4, pH 7.0 and
the elution buﬀer contained 200mM imidazole, 500mM
NaCl, 20mM Tris–Cl, pH 8.0. Eluents were subjected to
24h dialysis ﬁrst against 134mM KCl, 1mM Na2EDTA,
10mM KH2PO4, pH 7.0 and second against 500mM KCl,
10mM HEPES, pH 7.0, followed by concentration to
0.5–10mg/ml using Amicon Ultra 4 (Millipore) centrif-
ugal concentrators with a 10000 molecular weight
cutoﬀ. CT activity was measured in the reverse, or
non-physiological, direction with a spectrophotometric
assay in which the production of acetyl-CoA was
coupled to citrate synthase and malate dehydrogenase
reactions (8). NADH formation was followed spectropho-
tometrically at 340nm using a Uvikon 810 (Kontron
Instruments) spectrophotometer interfaced to a
computer equipped with a data acquisition program.
Inactivation studies
Enzyme modiﬁcation by N-ethylmaleimide (NEM) was
performed in 500mM KCl, 10mM HEPES, pH 7.0. For
NEM inactivation, reactions were initiated by the addition
of NEM to the CT solution at a ﬁnal concentration of
4mM. An aliquot was removed every 5min and assayed
for enzymatic activity. The aliquots were of suﬃciently
small volume compared with the assay volume such that
the modifying agents were diluted 50-fold.
Data analysis
The kinetic parameters Km and Vmax were determined by
nonlinear regression analysis. The initial velocities versus
the substrate concentration were ﬁtted to the Michaelis–
Menten equation using the programs of Cleland (10). The
dissociation constant (Kd) for RNA binding was deter-
mined using the program Enzﬁtter. The binding isotherms
for CT binding to RNA were analyzed by ﬁtting the data
to Equation 1, where Kd reﬂects half maximal saturation,
Y is the fractional complex, X is concentration of CT and
Ymax is the maximal complex or horizontal asymptote.
Y ¼ Ymax   X=ðKd þ XÞ 1
Zinc determination and circular dichroism
The molar ratio of Zn to CT tetramer was determined
using Atomic Absorption Spectroscopy using a Varian
Spectra AA 220 Atomic Absorption Spectrometer
equipped with a zinc lamp and absorption recorded at
213.9nm. Protein concentrations for wild-type and
variants ranged from 15 to 50mM. CD spectra were
recorded on an AVIV Model 202 CD spectropolarimeter
using a 1cm pathlength quartz cuvette. Data points were
averaged from triplicate scans from 200 to 250nm.
Spectra for wild-type and each variant were recorded at
25 C at a protein concentration of 0.1mg/ml ina buﬀer of
500mM KCl, 10mM HEPES, pH 7.0.
DNA Electrophoretic mobility shift assay
Wild-type CT and variants were incubated for 0.5h at
25 C with an 800bp linear dsDNA at ﬁnal concentrations
of 0.88mM and 50nM, respectively. The DNA was
obtained by gel extraction following PCR using primers
C46A5 and CTb3 and the accD gene as the template. After
addition of glycerol to a ﬁnal concentration of 2.5%,
samples were resolved on 0.8% (w/v) agarose gels in
1 TAE (40mM Tris–Cl at pH 8.0, 20mM acetate,
1mM Na 2EDTA) followed by staining with ethidium
bromide and visualized by UV irradiation.
In vitro transcription and RNA electrophoretic mobility
shift assay
A cell-free extract was used to produce mRNA using the
MEGAscript Kit (Ambion) following the manufacturer’s
protocol with 0.2mg PCR product as the template. Each
20ml reaction contained [a-
32P]UTP at 167nM. The reac-
tions also contained 7.5mM ATP, CTP, GTP and
3.75mM UTP. The resultant mRNA was puriﬁed
according to the manufacturer’s instructions with the
MEGAclear Kit (Ambion) and eluted in 100ml, to which
was added 20ml of 80% glycerol and 20mlo f1 0 EMSA
buﬀer (200mM Tris–Cl at pH 8.0, 1mM Na2EDTA,
500mM NaCl, 50mM MgCl2). Seven microliter of this
solution was added to each 10ml reaction, with CT
titrated from 0 to 1mM in the remaining 3ml. For
the inhibition of RNA binding, acetyl-CoA was titrated
from 0 to 4.0mM. Reactions were incubated on ice
for 0.5h. Samples were loaded with the power on onto
prerun 5.0% (w/v) native polyacrylamide gels (39:1
acrylamide:bisacrylamide) and electrophoresed at room
temperature in TBE buﬀer (45mM Tris borate at pH
8.3, 1.25mM Na2EDTA). After 3–6h of electrophoresis,
the gels were dried and complexes were visualized by phos-
phorimaging and quantiﬁed using Molecular Dynamics
ImageQuant software. The protein–RNA complex was
deﬁned as the slowest migrating band on the gel, while
free RNA was the lower band. For calculating percent
complex formation, the region on the gel from the
slowest migrating complex to the free nucleic acid was
considered as complex. The percent complex was cal-
culated as complex intensity divided by total intensity
(complex plus free RNA). Each gel shift was done in at
least duplicate.
Coupled in vitro transcription/translation
Translation repression of the mRNA encoding the a- and
b-subunits via CT binding was examined using a coupled
in vitro transcription/translation system. The EasyXpress
Nucleic Acids Research,2010, Vol.38, No. 4 1219Protein Synthesis System (Qiagen) was used following the
manufacturer’s protocol with 1mg(  10nM) plasmid or
unlabeled mRNA as templates. To examine the eﬀect of
CT on the expression of both genes simultaneously,
pCZB5 was used as a template. The plasmid pCZB5 is
an expression vector of similar construction to pGDM9
and contains the accA and accD genes in tandem with high
levels of overexpression from those genes (8). The ability
of CT to attenuate translation of only the mRNA for
the b-subunit utilized the vector pGLW39, which
contains only the accD gene cloned into pET28. The
proteins expressed from these templates were visualized
by polyacrylamide gel electrophoresis, where each 50ml
reaction contained 5mCi of [
35S]L-Methionine. The
reaction mixtures were run on 5.0% (w/v) denaturing
polyacrylamide gels (39:1 acrylamide:bisacrylamide,
2.5% SDS) at 2V/cm for 10–12h and dried. Bands were
visualized by phosphorimaging. Each assay was done in
triplicate.
Detection of CT–RNA interaction in situ
Detection of CT binding to RNA in situ was accomplished
using a ﬂuorescence resonance energy transfer (FRET)
assay with a CT b-enhanced yellow ﬂuorescent protein
(eYFP) fusion protein as the donor and the RNA
binding dye Sytox Orange (Molecular Probes) as the
acceptor. The gene for eYFP was ampliﬁed with primers
eYFP5 and eYFP3, digested with XhoI and PacI, and
cloned into equivalently digested pGDM9 and pGDM18
to generate pGDM24 and pGDM25, respectively. The use
of XhoI and PacI restriction sites eliminates the
vector-encoded His6-tag and stop codon, while placing
the stop codon following the coding region for the CT
b-eYFP fusion protein. Plasmid pGDM24 contains
wild-type CT-eYFP fusion and pGDM25 contains the
quadruple cysteine variant of CT-eYFP fusion. E. coli
BL21(DE3) harboring the plasmids pGDM24 and
pGDM25 were grown at 37 C until the A600 reached
0.7, at which point lactose was added to 28mM.
Samples of 100ml were collected just prior to induction
with lactose, and every 0.5h afterward for 3h and ﬂash
frozen in liquid nitrogen. Each sample was then thawed
and divided equally into thirds. The divided samples were
either left as is, subjected to 0.3mg/ml RNase A (Qiagen),
or 1.0 U/ml DNase I for 0.5h at 37 C. Sytox Orange is a
high-aﬃnity nucleic acid stain that readily enters cells with
compromised membranes. The dye was added to control
and nuclease treated cells to a ﬁnal concentration of
250nM. There is considerable overlap of YFP emission
and Sytox Orange absorption spectra; the Fo ¨ erster
distance (R0) is 5.6nm. Spectra were collected using a
Jasco FP-6300 spectroﬂuorometer equipped to hold a
3   3mm quartz cuvette. A 500nm incident light was
used to achieve suﬃcient FRET with minimal direct exci-
tation of the acceptor. Emission spectra were measured
perpendicular to the incident light at 540–600nm to
avoid the peak due to refracted light and to suﬃciently
span the absorption maximum of 573nm when the stain is
bound to nucleic acid. Each assay was done in triplicate.
RESULTS
The Zn domain is required for catalysis and
nucleic acid binding
The Zn ﬁnger of CT is a member of the Cys4-type family,
with the divalent metal coordinated in a tetrahedral
fashion by four cysteine sulfhydryl groups (Figure 1).
Each of the cysteines (residues 27, 30, 46 and 49)
coordinating the zinc atom were mutated to alanine indi-
vidually followed by multiple mutations to remove two
(double; C27A, C46A), three (triple; C27A, C46A,
C49A), and all four (quadruple) cysteines.
The eﬀect of the cysteine mutations on enzymatic
activity was assessed using a coupled enzyme assay
where the reaction is run in the non-physiological direc-
tion in which malonyl-CoA and biocytin [biocytin is a
biotin molecule with a lysine aﬃxed to the carboxyl
group of the valeric acid side chain via an amide linkage
at the e-amino group and is preferred over biotin in this
assay because it produces a maximal velocity three orders
of magnitude greater than does biotin (8)] are the
substrates. The kinetic results indicate that mutation of
individual cysteine residues 27, 46 and 49 decreases the
Vmax only 8- to 11-fold, whereas the Vmax for the C30A
variant decreases by over 100-fold (Table 2). Similar
results were obtained with analogous mutations to the
Cys4-type zinc ﬁnger of pea plastidic ACCase CT b (11).
Mutation of a single cysteine has only small eﬀects on the
Michaelis constant for both substrates, biocytin and
malonyl-CoA. None of the multiple site variants have
measureable activity. The results suggest that the
Zn-ﬁnger cysteines are not directly involved in substrate
binding, but rather play a role in the catalytic step or
product release.
The decrease in activity as a result of mutating the
cysteines in the zinc domain explains earlier observations
that the thiol modifying reagent N-ethylmaleimide
(NEM) inactivated carboxyltransferase and that the
substrate malonyl-CoA protected against inactivation
(8). Reaction of NEM with the most active single-site
Table 2. Steady state kinetic parameters for wild-type CT and
variants
Construct Vmax
(min
 1)
Km (biocytin,
mM)
Km
(malonyl-CoA,mM)
Wild-type CT 211±7 11.4±0.4 40.0±5.6
C27A 22.8±1.4 11.5±0.5 53.2±9.2
C30A 1.5±0.2 5.0±1.1 20.2±2.4
C46A 18.8±0.7 4.0±0.7 72.2±10.4
C49A 26.7±0.9 9.7±0.6 106.8±9.8
C27/46A ‘double’ 0
C27/46/49A ‘triple’ 0
C27/30/46/49A
‘quadruple’
0
The apparent maximal velocities and Michaelis constant for biocytin
were obtained by varying biocytin while holding malonyl-CoA constant
at 100mM. The apparent Michaelis constant for malonyl-CoA was
obtained by varying malonyl-CoA while holding biocytin constant at
20mM. The standard errors on Vmax and Km were determined from the
nonlinear regression analysis.
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ity to NEM when normalized and compared to wild-type
(data not shown), which is consistent with NEM modify-
ing these cysteine residues in the zinc domain and in
turn aﬀecting enzymatic activity. In addition, the
location of the zinc domain on the b-subunit (which
contains the malonyl-CoA binding site) is consistent
with malonyl-CoA protecting against inactivation.
Mutation of the cysteines in the zinc domain not only
aﬀected catalytic activity but also nucleic acid binding. An
electrophoretic mobility shift assay (EMSA) was used to
assess the eﬀect of the mutations on CT binding to DNA
(Figure 2). CT with single substitutions at positions 27, 46
and 49 appear to exhibit diminished DNA-binding
capacity as evidenced by complex dissociation during
electrophoresis, while the C30A variant and the multiple
cysteine variants fail to form stable complexes with the
DNA. Thus, the zinc-ﬁnger cysteines are required for
DNA-binding, as expected.
Substitution of the cysteines likely altered the
electrostatic structure of the zinc ﬁnger, resulting in the
loss of zinc coordination. The eﬀect of the mutations on
the molar zinc content was determined using atomic
absorption spectroscopy. Wild-type CT had two zinc
atoms per CT tetramer as predicted from the structure.
CT with single-site substitutions at cysteines 27, 46 and
49 contained 1.2–1.3 zinc atoms per CT tetramer, while
the C30A variant had only 0.76 zinc atoms per CT
tetramer. CT variants with multiple substitutions show
progressively lower occupancies decreasing from 0.52 to
0.29 molar ratios. Circular dichroism spectroscopy
was used to determine if the mutations had an eﬀect on
the overall secondary structure. CT variants C30A, C46A
and C49A show spectra similar to wild-type CT
(Supplementary Figure S1). The spectra for the C27A
and variants with double and triple substitutions show suc-
cessive changes in the 205–215nm range; the spectrum of
CT lacking all four cysteines has much more extensive
changes ranging from 205 to as far as 240nm. The
eﬀects of the mutations on catalysis and nucleic acid
binding are likely due to loss of the zinc atom and alter-
ation in secondary structure and they clearly demonstrate
that the zinc domain is the structural feature of CT that
links nucleic acid binding with catalysis.
Carboxyltransferase binds preferentially to the a- and
b-subunit mRNA
Earlier DNA binding studies showed that DNA binding
was non-speciﬁc and cooperative with half-maximal
saturation of about 1mM for a variety of DNA sequences,
indicating that DNA binding was not likely to be the
physiological role of the zinc domain of carboxyl-
transferase (7). However, considering that the closest
structural homolog of the carboxyltransferase
Zn-domain is the zinc domain from the 50S ribosomal
protein L37Ae (6), the ability of carboxyltransferase to
bind RNA was investigated. Four diﬀerent types of
RNA were tested for their ability to inhibit formation of
the CT–DNA complex. The RNA molecules considered
included mRNA coding for the a-subunit, mRNA coding
for the b-subunit, a total RNA extract from E. coli, and
tRNA from Saccharomyces cerevisiae. All four types of
RNA were found to inhibit formation of the CT–DNA
complex (data not shown). Notably, a qualitative compar-
ison of the data showed that mRNA coding for the a- and
b-subunits inhibited complex formation more eﬀectively.
A transcript including the a-subunit mRNA starting
213nt upstream of the AUG through the end of the struc-
tural gene was therefore used in an EMSA (Figure 3).
In contrast to the sigmoidal binding isotherm obtained
for carboxyltransferase binding to DNA, fractional
carboxyltransferase–RNA complex formation is best ﬁt
to a hyperbolic curve, yielding a half-maximal binding
constant (Kd) of 145±9nM, which is about 7-fold
lower than the half-maximal saturation for DNA
binding. When the data were ﬁtted to the Hill equation
a Hill coeﬃcient of  1 was calculated, indicating a lack of
cooperativity (not shown). Moreover, the data were also
analyzed according to Hensley et al. (12), which uses
various linear transformations to detect a low degree of
positive cooperativity. These analyses also indicate that
the degree of cooperativity for subunit mRNA binding
to carboxyltransferase is either very small or nonexistent.
The tighter binding and hyperbolic binding isotherm for
carboxyltransferase mRNA complex formation may
suggest preferred binding to speciﬁc sites.
The CT binding site is within the a- and b-subunit mRNA
coding region
To determine the region(s) of mRNA to which CT is
binding, a series of linear DNA templates were con-
structed from which mRNAs of various lengths were
transcribed using runoﬀ transcription (Figure 4).
Electrophoretic mobility shift assays were used to
measure the Kd for each RNA construct binding to
wild-type CT. Starting with the natural transcription
start site of accA and ending with the stop codon,
the 1183nt transcript yielded a Kd of 136±10nM.
Figure 2. An ethidium bromide-stained 0.8% agarose gel image of
DNA binding by CT and variants. Lanes 1–9 contain an 800bp
linear dsDNA with the following proteins: 1, no protein; 2, wtCT; 3,
C27A; 4, C30A; 5, C46A; 6, C49A; 7, double variant; 8, triple variant;
9, quadruple variant.
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deletions generated a 886nt CT a RNA to which CT
bound more tightly with a Kd of 48±8nM, while
further truncation resulted in a marked decrease in the
ability of CT to bind the RNA. The shortest transcripts
consisting only of the 50 UTR yielded no complex on incu-
bation with CT. To conﬁrm that the 50 UTR region is not
involved in CT binding, similar sized templates were made
without the 50 UTR and tested for CT binding. The
longest transcript lacking the 50 UTR but containing the
entire a-subunit coding region (966nt) bound to CT with a
Kd of 250 ± 20nM. The 684nt transcript representing a
30-truncation yielded a CT–RNA complex, however the
fractional complex could not be measured due to the exis-
tence of numerous CT–RNA complexes comigrating with
free RNA. The shortest transcript (328nt) showed no
ability to bind to CT.
A series of templates similar to the ones described above
for accA were also made for the accD coding region
(Figure 4). The 50 UTR was excluded from the accD
transcripts because it was found not to play a role in CT
binding to accA mRNA. The transcript (912nt) contain-
ing the entire open reading frame of CT b had a Kd of
290±20nM, while truncating 228nt from the 30-end
(684nt transcript) resulted in a decrease in Kd to
83±9nM. This pattern for the two longest transcripts
was also observed with accA. Moreover, just as with
accA, shorter transcripts of accD bound CT only poorly.
Comparison of the a- and b-subunit mRNA regions
required for CT binding reveals a striking similarity. For
both subunits, 684nt fragments beginning at the start sites
were optimal. Within this sequence were 356nt in a
mRNA, and 335nt in b mRNA that translate into
Figure 4. mRNA in vitro transcription products.
Figure 3. (A) Electrophoretic analysis of the transcript from CT
a-subunit titrated with CT. (A) All lanes contain 50fmol
32P-labeled
mRNA, while lanes 2–15 contain 1.0, 5.0, 10, 25, 40, 55, 70, 85, 100,
200, 300, 400, 500 and 600nM CT. (B) Binding isotherm for CT
binding to the transcript from CT a-subunit. The points represent
averages from triplicate measurements. The error bars shown are the
standard deviation. The curve represents the best ﬁt of the data to
Equation 1. No conclusions about the stoichiometry of binding can
be made from this curve.
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compared to the alignment of the entire protein sequence
(30%). This region of the mRNA of the a- and b-subunits
will be hereafter referred to as the ‘symmetry box’. All
RNA constructs from either subunit that excluded this
region lacked the ability to bind CT, suggesting its contri-
bution to enzyme recognition. Two additional templates
were constructed consisting of only the regions from each
gene representing this symmetry box to determine whether
these regions are not only necessary, but suﬃcient for CT
binding. Neither transcript had any aﬃnity for CT,
indicating that regions upstream of the symmetry box
are also necessary for CT binding. The upstream region
and the symmetry box must be connected for binding to
CT because simply combining the two regions individually
did not result in CT binding for either mRNA (data not
shown).
Carboxyltransferase inhibits translation of a- and
b-subunit mRNA
If CT binds to the mRNA coding for the a- and
b-subunits, then does CT binding inhibit translation of
the mRNA? This question was addressed using an
in vitro coupled transcription/translation reaction. The
mRNA for both a- andb-subunits was generated by tran-
scription from a plasmid containing the genes for both
subunits. The reaction was carried out in the presence of
35S-labeled methionine, and products separated on a
polyacrylamide gel and visualized by phosphorimaging
(Figure 5). Increasing amounts of unlabeled wild-type
CT added to the reaction prior to initiation by addition
of plasmid progressively decreased the in vitro synthesis of
CT (Figure 5, lanes 6–10). The decrease in expression in
the presence of unlabeled CT is not due to an inhibition of
transcription because CT also inhibited translation when
an mRNA transcript was used to initiate expression
(Figure 5A, lanes 3 and 4). The inhibition of translation
was partially reversed by the addition of the substrate
acetyl-CoA, indicating a reversible competition between
mRNA and substrate and consistent with the notion
that nucleic acid binding and catalysis are mutually exclu-
sive (Figure 5A, lanes 11–15). To ensure that CT binding
to a mRNA does not aﬀect translation of the b-subunit,
the ability of CT to inhibit translation of the b-subunit
mRNA was examined. The coupled transcription/transla-
tion reaction from a plasmid containing only the accD
gene showed that CT does indeed inhibit translation of
the b-subunit mRNA (Figure 5B, lanes 4–7). The inhibi-
tion was again relieved by the substrate acetyl-CoA
(Figure 5B, lanes 8–11). The inhibition of translation
was speciﬁc for the mRNA coding for the a- and
b-subunits because CT did not inhibit translation of the
gene coding for the 32kDa elongation factor EF-Ts which
was provided as a control in the in vitro coupled transcrip-
tion/translation reaction (Figure 5C). Reinforcing the role
of the zinc domain in nucleic acid binding, addition of the
quadruple variant of CT had no eﬀect on the level of
translation (data not shown.)
To conﬁrm that acetyl-CoA relieved inhibition of trans-
lation by reversible competition between mRNA and the
substrate acetyl-CoA, inhibition of CT–RNA complex
formation by acetyl-CoA was examined. The transcript
(912nt) containing the entire open reading frame of CT
b was incubated with 166nM CT and increasing amounts
of acetyl-CoA (Figure 6A). With increasing [acetyl-CoA],
a concomitant decrease in CT–RNA complex formation is
evident. This demonstrates reversible competition between
mRNA and substrate. Conversely, since the substrate
acetyl-CoA inhibited the binding of CT to RNA, and
given that catalysis and nucleic acid binding in CT are
linked through the zinc domain, RNA should inhibit
catalysis as well. An 1183nt CT a mRNA was found to
inhibit CT activity in a dose-dependent manner, with
nearly a 4-fold drop in activity at 90nM (Figure 6B).
Figure 5. Five percent denaturing polyacrylamide gels of in vitro
coupled transcription/translation reactions expressing
35S-labeled
proteins. (A) Lane 1, no DNA template. Lane 2, positive control test
plasmid encoding the 32kDa elongation factor EF-Ts protein. Lane 3,
polycistronic mRNA generated in vitro from pCZB5 plasmid showing
CT a (37kDa) and CT b (33kDa). Lane 4, same as lane 3 with the
addition of 166nM unlabeled wild-type CT to the transcription/trans-
lation reactions. Lanes 5–15 contain 1mg(  10nM) pCZB5 plasmid.
Lanes 5–10 contain 0, 63, 125, 250, 500 and 1000nM unlabeled
wild-type CT. Lanes 10–15 contain 1mM unlabeled wild-type CT and
acetyl-CoA at 0, 88, 175, 350, 700 and 1400mM. (B) Lane 1, no DNA
template. Lane 2, positive control test plasmid showing a 32kDa
protein. Lane 3–11 contain 1mg(  10nM) pGLW39 plasmid. Lanes
3–7 contain 0, 63, 125, 250 and 1000nM unlabeled wild-type CT.
Lanes 7–11 contain 1mM unlabeled wild-type CT and acetyl-CoA at
0, 175, 350, 700 and 1400mM. (C) Lane 1, no DNA template. Lanes
2–8 contain positive control test plasmid as in (A), lane 2. Lanes 3–8
contain 31, 63, 125, 250, 500 and 1000nM unlabeled wild-type CT.
Nucleic Acids Research,2010, Vol.38, No. 4 1223As a control, CT retained >80% activity in the presence of
a 90nM 1040nt mRNA coding for EF-Ts (Figure 6B);
that EF-Ts inhibits CT activity at higher concentrations
is consistent with the nonspeciﬁc binding to nucleic acids
reﬂected in DNA binding. These results conﬁrm that
mRNA binding to CT inhibits enzymatic activity.
CT–RNA interaction occurs in situ
CT binds to RNA in vitro, but does CT interact with RNA
in the context of a cell? To address this issue, a FRET
(ﬂuorescence resonance energy transfer) assay was used.
The assay is based on the work of Lorenz (13) and utilized
eYFP (enhanced yellow ﬂuorescent protein) fused to
wildtype or the quadruple variant of CT b as the donor
and the nucleic acid stain Sytox Orange as the acceptor.
Cells containing plasmids where the genes for CT a and
either wildtype CT b fused to eYFP or quadruple variant
CT b fused to eYFP were induced to express the CT a
and CT b-eYFP fusion proteins. After 0–3h, samples were
freeze-thawed followed by various nuclease digestions.
Sytox Orange was added to the treated cells and ﬂuores-
cence was measured to determine proximity of CT b-eYFP
to nucleic acid-bound stain. As shown in Figure 7a FRET
signal was observed only after induction of protein expres-
sion (blue trace). The maximal signal occurred 1h after
induction with no change up to 3h post-induction. Little
to no signal was detected prior to induction (purple trace).
Since Sytox Orange can also bind to DNA, cells were
treated with DNase or RNase in order to conﬁrm the
signal is a result of RNA interaction. Treatment with
DNase I had little eﬀect on the ﬂuorescence signal (red
trace); however, digestion with RNase A attenuated the
signal to near pre-induction levels (green trace). The qua-
druple variant-eYFP fusion protein showed no FRET
signal consistent with its inability to bind nucleic acids
(orange trace). These data indicate that in situ the
primary nucleic acid binding target of CT is RNA.
While these results show that CT prefers to bind to
RNA over DNA in the cell, they do not address the
question of RNA speciﬁcity. As a control, the CT
b-eYFP fusion protein was expressed, puriﬁed, and
shown in vitro to exhibit ﬂuorescence with 500nm
incident light. The emission peak at 547nm drops
signiﬁcantly with a concomitant appearance of a new
emission peak at 574nm upon addition of Sytox Orange
to the sample (data not shown). This indicates a functional
donor/acceptor pair for FRET with an excitation wave-
length of 500nm.
DISCUSSION
The zinc domain is required for enzymatic activity and
translational repression
Site-directed mutagenesis of the zinc domain conclusively
establishes that it is the structural link between nucleic
acid binding and catalysis. The coupling of nucleic acid
binding to catalysis implies a selective pressure to
maintain the zinc domain on the b-subunit and that the
ability to bind nucleic acids has a speciﬁc purpose; consis-
tent with this inference, we ﬁnd that CT binds RNA
in situ. Notably, in vitro analyses demonstrate that CT
preferentially binds the mRNA encoding its own a- and
b-subunits, implying the existence of an uncommon regu-
latory mechanism.
Figure 6. (A) Electrophoretic analysis of the transcript from CT
b-subunit titrated with CT. All lanes contain 50fmol
32P-labeled
mRNA, lane 1 contains only mRNA, while lanes 2–14 contain
166nM CT and acetyl-CoA at 0, 20, 50, 100, 200, 300, 400, 500,
600, 750, 1000, 2000 and 4000mM. (B) RNA inhibition of CT
activity. Circles represent averages from triplicate measurements for
reactions containing the 1040nt EF-Ts transcript at 0, 11.3, 22.6,
45.3 and 90.6nM. Triangles represent averages from triplicate measure-
ments for reactions containing the 1183nt CT a transcript at 0, 11.6,
23.2, 46.4 and 92.8nM. The error bars shown are the standard devia-
tion. Note that enzymatic reactions contain only 1mM KCl, conditions
under which the aﬃnity of CT for RNA is higher than that determined
from EMSA assays.
Figure 7. FRET emission scan showing absorption peak generated by
incident light at 500nm. Blue trace, wild-type CT fused to eYFP, 1h
post-induction, not subjected to nucleic acid digestion. Purple trace,
wild-type CT fused to eYFP, pre-induction, not subjected to nucleic
acid digestion. Red trace, wild-type CT fused to eYFP, 1h
post-induction, treated with DNase. Green trace, wild-type CT fused
to eYFP, 1h post-induction, treated with RNase. Orange trace, qua-
druple variant CT fused to eYFP, 1h post-induction, not subjected to
nucleic acid digestion.
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b-subunits inhibited translation in a dose-dependent
manner, while the substrate acetyl-CoA inhibited RNA
binding and relieved the inhibition of translation also in
a dose-dependent manner. Consistent with the coupled
nature of nucleic acid binding and catalysis by CT, the
mRNA also inhibited catalysis. These ﬁndings indicate a
physiological role for the zinc domain in regulating not
only production of the a- and b-subunits of CT, but also
its enzymatic activity. The basic premise of the model of
regulation illustrated in Figure 8 is that in bacteria, fatty
acids are only used for membrane biogenesis, hence
carboxyltransferase is only needed when nutrients are
abundant. In contrast, during the stationary phase of
E. coli growth where nutrients are limited, carbo-
xyltransferase would act as a ‘dimmer switch’ on the
expression of the a- and b-subunits by binding to the
mRNA and inhibiting translation. Reciprocally, RNA
binding by CT renders it catalytically inactive, limiting
unneeded and wasteful conversion of acetyl-CoA to
malonyl-CoA. During the growth phase when nutrients
are abundant, the level of acetyl-CoA would increase dra-
matically and compete with the mRNA for binding to
carboxyltransferase. This alleviates both the inhibition of
catalytic activity and the repression of translation charac-
teristic of stationary phase, leading to increased levels of
CT and ultimately fatty acids. The levels of acetyl-CoA in
E. coli during the log phase (600mM) and stationary phase
(20mM) (14) are in accord with the data in Figure 5A,
because relief of translational repression was observed at
350mM acetyl-CoA, whereas very little protein production
was observed at 88mM acetyl-CoA. This model of regula-
tion is also consistent with reports that levels of the
mRNA coding for the a- and b-subunits do not change
appreciably between the log and stationary phases (15,16).
The model of regulation in Figure 8 also provides a
plausible explanation for how the cell maintains
stoichiometric amounts of the a- and b-subunits. Instead
of transcriptional control of gene expression of the genes
for the a- and b-subunits, bacteria appear to utilize
translational repression where CT binds to the mRNA
for both of its subunits.
The mechanism of gene regulation proposed here is not
without precedent. For example, thymidylate synthase
from both E. coli and humans contains a Cys4-type
zinc-binding motif and binds its own mRNA within the
protein-coding region, repressing translation (17–19).
Also, it is important to note that this type of regulation
is not found in eukaryotic carboxyltransferase because the
a- and b-subunits are fused to one another as well as to the
BC and BCCP components to form one polypeptide chain
and because the zinc domain is absent (20). The one excep-
tion to the multidomain homomeric ACCase found in
eukaryotes is the heteromeric ACCase found in plastids.
The chloroplast ACCase of all plants except for the
grasses (Graminae) consists of the same four subunits as
E. coli ACCase, but their genetic origins are diﬀerent (21).
The BC, BCCP and CT a peptides originate from
nuclear-encoded genes and are shuttled to the chloroplast
(22–24). The CT b protein, however, is expressed from a
chloroplast-encoded gene, and like the E. coli accD gene,
encodes a Cys4-type zinc-binding domain, which is consis-
tent with the theory that chloroplasts evolved from bacte-
rial symbiosis (24). Perhaps the zinc domain in chloroplast
CT b binds to the ;b mRNA to regulate translation in a
manner similar to the model presented here for E. coli CT.
A symmetry-based model
The fundamental tenet of the gene regulation model pre-
sented in Figure 8 rests on the ability of CT to bind the
mRNA encoding both a- and b-subunits. The molecular
basis of how it does so is rooted in the symmetry of the
chemical mechanism and 3D structure of CT. Transfer of
the carboxyl group from carboxybiotin to acetyl-CoA
Figure 8. Proposed mechanism for autoregulation of CT enzymatic activity and mRNA translation. The RNA-binding and catalytic functions of CT
are sensitive to the metabolic state of the cell. During stationary phase when de novo fatty acid synthesis is unneeded, glucose and thus acetyl-CoA
levels are low, allowing CT to bind the mRNA for its subunits, attenuating expression of the enzyme as well as enzymatic activity on remaining
acetyl-CoA stores.During log phase growth membrane biogenesis is needed. Glucose is abundant, increasing the availability of acetyl-CoA for fatty
acid synthesis. Acetyl-CoA binds to CT permitting translation of the mRNA for the a- and b-subunits. This ‘dimmer switch’ model gives the cell a
means of rapid response to changes in cellular metabolic state.
Nucleic Acids Research,2010, Vol.38, No. 4 1225involves formation of enolate or enolate-like anions in
both carboxybiotin and acetyl-CoA. To this end, both
the a- and b-subunits have evolved tertiary folds that sta-
bilize oxyanions. Acetyl-CoA binds to the b-subunit, while
carboxybiotin binds to the a-subunit and the tertiary
structure of both the a- and b-subunits contain a similar
a/b spiral core of two b-sheets surrounded by a-helices
suggesting a gene duplication event. This type of fold
places carboxyltransferase in the crotonase superfamily
of enzymes whose members all catalyze reactions that
generate enolate anions (25,26). Within the spiral core of
both the a- and b-subunits of CT are oxyanion holes
formed by main chain amides from glycine residues (6).
The regions of the mRNA for the a- and b-subunits that
bind to CT also reveal a symmetrical pattern. CT binds
only to the coding region of the mRNA of the a- and
b-subunits, a region that included the symmetry box,
which corresponds to the spiral core of the tertiary struc-
ture containing the oxyanion holes. While the symmetry
box is required for CT binding, it is not suﬃcient. The
mRNA upstream of the symmetry box is also needed for
binding, probably to achieve the proper 3D fold of mRNA
to interact with CT. This observation is consistent with the
notion that mRNA sequences close to the start site are
more likely to be involved in regulatory events. Thus,
while there are numerous examples of how the chemistry
of a reaction drives the evolution of enzyme structure, the
results presented here for carboxyltransferase not only
suggest a physiological role for the zinc domain but also
extend the concept of chemistry directing enzyme evolu-
tion to also include directing the mechanism of gene
regulation.
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